Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Romeu

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic responseR Paredes, T Puig, A Arnó, et al.
Polymers|October 27, 2022
The Use of 3D Optical Coherence Tomography to Analyze the Architecture of Cyanobacterial Biofilms Formed on a Carbon Nanotube CompositeMaria J Romeu, Marta Lima, Luciana C Gomes, et al.
AIDS (London, England)|December 1, 1996
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddCL Ruiz, J Romeu, J Martínez-Picado, et al.
The Journal of Infectious Diseases|June 3, 1999
Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus loadA Arnó, L Ruiz, M Juan, et al.
Dalton Transactions (Cambridge, England : 2003)|February 25, 2026
Cyclam-based Cu(II) and Fe(III) complexes for antifouling coating developmentInês M Nunes, Bruno J C Vieira, João C Waerenborgh, et al.
International Journal of Molecular Sciences|December 11, 2022
Assessment of the Antibiofilm Performance of Chitosan-Based Surfaces in Marine EnvironmentsMarta Lima, Luciana C Gomes, Rita Teixeira-Santos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapyA Tuldrà, C R Fumaz, M J Ferrer, et al.
AIDS (London, England)|January 11, 2000
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan studyF García, H Knobel, M A Sambeat, et al.
AIDS (London, England)|December 22, 1999
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 studyF García, J Romeu, I Grau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy StudyF García, M M Alonso, J Romeu, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic responseR Paredes, T Puig, A Arnó, et al.
Polymers|October 27, 2022
The Use of 3D Optical Coherence Tomography to Analyze the Architecture of Cyanobacterial Biofilms Formed on a Carbon Nanotube CompositeMaria J Romeu, Marta Lima, Luciana C Gomes, et al.
AIDS (London, England)|December 1, 1996
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddCL Ruiz, J Romeu, J Martínez-Picado, et al.
The Journal of Infectious Diseases|June 3, 1999
Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus loadA Arnó, L Ruiz, M Juan, et al.
Dalton Transactions (Cambridge, England : 2003)|February 25, 2026
Cyclam-based Cu(II) and Fe(III) complexes for antifouling coating developmentInês M Nunes, Bruno J C Vieira, João C Waerenborgh, et al.
International Journal of Molecular Sciences|December 11, 2022
Assessment of the Antibiofilm Performance of Chitosan-Based Surfaces in Marine EnvironmentsMarta Lima, Luciana C Gomes, Rita Teixeira-Santos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapyA Tuldrà, C R Fumaz, M J Ferrer, et al.
AIDS (London, England)|January 11, 2000
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan studyF García, H Knobel, M A Sambeat, et al.
AIDS (London, England)|December 22, 1999
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 studyF García, J Romeu, I Grau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy StudyF García, M M Alonso, J Romeu, et al.
Pageof 13